Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6505)
All Articles published online
|
Publishing Process of This Article
|
Jun 24, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Byrne TJ, Rakela J. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World J Transplant 2016; 6(2): 306-313 [PMID: 27358775 DOI: 10.5500/wjt.v6.i2.306] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i2/306.htm |
| Number | Citing Articles |
| 1 |
Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim. Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives. Cancers 2023; 15(15): 3988 doi: 10.3390/cancers15153988
|
| 2 |
Allison N. Martin, Luke R. Wilkins, Deepanjana Das, Lily E. Johnston, Todd W. Bauer, Reid B. Adams, Victor M. Zaydfudim. Efficacy of Radiofrequency Ablation versus Transarterial Chemoembolization for Patients with Solitary Hepatocellular Carcinoma ≤3 cm. The American Surgeon 2019; 85(2): 150 doi: 10.1177/000313481908500220
|
| 3 |
Marine Soret, Jacques-Antoine Maisonobe, Philippe Maksud, Stéphane Payen, Manon Allaire, Eric Savier, Charles Roux, Charlotte Lussey-Lepoutre, Aurélie Kas. Feasibility of Liver Transplantation after 90Y Radioembolization: Lessons from a Radiation Protection Incident. Health Physics 2024; doi: 10.1097/HP.0000000000001814
|
| 4 |
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, Zhihong Zhang, Li Liu, Dehua Wu, Jingyuan Sun. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. Cell Death & Disease 2022; 13(2) doi: 10.1038/s41419-022-04596-0
|
| 5 |
Won Chang, Jeong Min Lee, Jeong Hee Yoon, Dong Ho Lee, Sang Min Lee, Kyoung Bun Lee, Bo Ram Kim, Tae-Hyung Kim, Seunghyun Lee, Joon Koo Han, Gianfranco D. Alpini. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers. PLOS ONE 2017; 12(4): e0176350 doi: 10.1371/journal.pone.0176350
|
| 6 |
Silvia Cesario, Virginia Genovesi, Francesca Salani, Enrico Vasile, Lorenzo Fornaro, Caterina Vivaldi, Gianluca Masi. Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution. Life 2023; 13(7): 1562 doi: 10.3390/life13071562
|
| 7 |
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
|
| 8 |
Hla‐Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, Kenny Wong, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle. Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian setting. Cancer Medicine 2017; 6(9): 2017 doi: 10.1002/cam4.1119
|
| 9 |
Sophia Schmitz, Georg Lurje, Florian Ulmer, Anne Andert, Philipp Bruners, Maximilian Schulze-Hagen, Ulf Neumann, Wenzel Schoening. Loco-regional hepatocellular carcinoma treatment services as a bridge to liver transplantation. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 228 doi: 10.1016/j.hbpd.2019.01.004
|
| 10 |
Ana-Maria Bucalau, Illario Tancredi, Gontran Verset. In the Era of Systemic Therapy for Hepatocellular Carcinoma Is Transarterial Chemoembolization Still a Card to Play?. Cancers 2021; 13(20): 5129 doi: 10.3390/cancers13205129
|
| 11 |
|
| 12 |
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents. Abdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
|
| 13 |
Sae-Jin Park, Jae Hyun Kim, Jeong Hee Yoon, Jeong Min Lee. Comparison of Ablation Performance between Octopus Multipurpose Electrode and Conventional Octopus Electrode. Korean Journal of Radiology 2023; 24(2): 86 doi: 10.3348/kjr.2022.0600
|
| 14 |
Sandeep A. Ponniah, Andreas G. Zori, Roniel Cabrera. Liver Cancer. 2021; : 127 doi: 10.36255/exonpublications.livercancer.2021.ch7
|
| 15 |
William C. Chapman, Kevin M. Korenblat, Kathryn J. Fowler, Nael Saad, Adeel S. Khan, Vijay Subramanian, Maria B. Majella Doyle, Leigh Anne Dageforde, Benjamin Tan, Patrick Grierson, Yiing Lin, Min Xu, Elizabeth M. Brunt. Hepatocellular carcinoma: Where are we in 2018?. Current Problems in Surgery 2018; 55(11): 450 doi: 10.1067/j.cpsurg.2018.10.002
|
| 16 |
Alberto Unzueta, Roniel Cabrera. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma. Clinics in Liver Disease 2017; 21(2): 231 doi: 10.1016/j.cld.2016.12.002
|
| 17 |
Alfonso Jose Holguín Holguín, Juan Sebastián Toro Gutierrez, Luis Alfonso Bustamante-Cristancho, Tatiana Alvarez Saa, Juan C. Camacho. Bland Embolization and Transarterial Chemoembolization in Hepatocarcinoma. Digestive Disease Interventions 2024; 8(01): 52 doi: 10.1055/s-0043-1772742
|
| 18 |
Heng Li, Yao Liu, Can Cheng, Yang Wu, Shu-Hang Liang, Liang Wu, Hong Wang, Cong-yin Tu, Han-Hui Yao, Fan-Zheng Meng, Bo Zhang, Wei Wang, Jia-Bei Wang, Lian-Xin Liu. UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma. Cell Death & Disease 2023; 14(12) doi: 10.1038/s41419-023-06369-9
|